1990
DOI: 10.1136/adc.65.2.196
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacokinetics of prednisolone in children with nephrosis.

Abstract: The pharmacokinetics of prednisolone given intravenously were studied in 11 children with relapsed steroid responsive nephrotic syndrome, and four control subjects. The clearance of both total and unbound drug was decreased in these children and the unbound fraction of the drug in plasma was significantly correlated with the degree of hypoalbuminaemia. We conclude that changes in the clearance of prednisolone and altered protein binding might account for some of the variability in both therapeutic responses an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
10
0

Year Published

2003
2003
2018
2018

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(10 citation statements)
references
References 13 publications
0
10
0
Order By: Relevance
“…Although pulse steroid therapy involves single administrations of the same amount of steroids administered over 1 month in standard treatment, it has been suggested that the reason why it has fewer side effects relative to the amount used is that the serum pharmacokinetics of methylprednisolone in pulse steroid therapy are different from those of prednisolone, which is administrated orally and intravenously in standard treatment. In other words, as reported by Vree et al [17], although the half-life of the prednisolone that is administrated orally and intravenously in standard treatment is 2.7–3.7 h [13,14,15,16], the half-life of methylprednisolone used in pulse steroid therapy is shortened to 1.4 h [17]. In sum, there is a possibility that the fact that the half-life of methylprednisolone in pulse steroid therapy is half of that of the prednisolone of standard treatment contributes to the reduction of side effects.…”
Section: Discussionmentioning
confidence: 86%
“…Although pulse steroid therapy involves single administrations of the same amount of steroids administered over 1 month in standard treatment, it has been suggested that the reason why it has fewer side effects relative to the amount used is that the serum pharmacokinetics of methylprednisolone in pulse steroid therapy are different from those of prednisolone, which is administrated orally and intravenously in standard treatment. In other words, as reported by Vree et al [17], although the half-life of the prednisolone that is administrated orally and intravenously in standard treatment is 2.7–3.7 h [13,14,15,16], the half-life of methylprednisolone used in pulse steroid therapy is shortened to 1.4 h [17]. In sum, there is a possibility that the fact that the half-life of methylprednisolone in pulse steroid therapy is half of that of the prednisolone of standard treatment contributes to the reduction of side effects.…”
Section: Discussionmentioning
confidence: 86%
“…Miller et al [29] studied the relationship between percentage of unbound prednisolone (y) and plasma albumin concentration (x) and proposed a linear equation of y = −17.5x + 92. It should be noted that the Miller's equation does not take into consideration of the fact that the unbound fraction of prednisolone varies with the total prednisolone concentration as discussed above.…”
Section: Resultsmentioning
confidence: 99%
“…The serum pharmacokinetics of methylprednisolone in pulse steroid therapy seemed to be different from that of orally administrated prednisolone. The half‐life of orally and intravenously given prednisolone in the standard way has been reported to be 2.7–3.7 h independent from their doses in the previous studies 20–23 . In contrast, that of methylprednisolone was 1.4 h according to Vree's inspiring trial 24 .…”
Section: Discussionmentioning
confidence: 96%
“…The half-life of orally and intravenously given prednisolone in the standard way has been reported to be 2.7-3.7 h independent from their doses in the previous studies. [20][21][22][23] In contrast, that of methylprednisolone was 1.4 h according to Vree's inspiring trial. 24 Thus the half-life of methylprednisolone was twofold quicker than prednisolone, which might reduce side-effects.…”
Section: Discussionmentioning
confidence: 99%